Louis A. Matis
9Patents
4h-index
14Co-inventors
50Inventor score
Filing activity: May 2, 1994 → Jun 3, 2005
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6355245B1 | C5-specific antibodies for the treatment of inflammatory diseases | Chemistry; Metallurgy | 192 | Expired |
| US6074642A | Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis | Chemistry; Metallurgy | 87 | Expired |
| US6982323B1 | Chimeric proteins for diagnosis and treatment of diabetes | Chemistry; Metallurgy | 32 | Expired |
| US7279158B2 | Methods for the treatment of inflammatory joint disease | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5891645A | Porcine E-selectin | Chemistry; Metallurgy | 3 | Expired |
| US6040428A | Porcine E-selectin | Chemistry; Metallurgy | 1 | Expired |
| US7384915B2 | Chimeric insulin-gad proteins for treating patients with type 1 diabetes or at risk of developing type 1 diabetes | Chemistry; Metallurgy | 0 | Expired |
| US7041503B2 | Modified myelin basic protein molecules | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7405279B2 | Chimeric proteins for diagnosis and treatment of diabetes | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.